Terms: = Endocrine gland cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Prognosis
111 results:
1. Profiling of Tumour-Infiltrating Lymphocytes and Tumour-Associated Macrophages in Ovarian Epithelial cancer-Relation to Tumour Characteristics and Impact on prognosis.
Stout A; Facey N; Bhatnagar A; Rice K; Berditchevski F; Kearns D; Metcalf A; Elghobashy A; Shaaban AM
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674108
[TBL] [Abstract] [Full Text] [Related]
2. 5 signature genes revealed by single-cell profiling identified unique immune subtypes affecting the prognosis of ovarian cancer.
Xiang SY; Li QK; Yang Z; Yi Q
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):2051-2062. PubMed ID: 38497886
[TBL] [Abstract] [Full Text] [Related]
3. FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGF-beta1/SMAD2/3 signaling pathway in ovarian cancer.
Song G; Sun Z; Chu M; Zhang Z; Chen J; Wang Z; Zhu X
BMC Cancer; 2024 Jan; 24(1):122. PubMed ID: 38267923
[TBL] [Abstract] [Full Text] [Related]
4. Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma.
Chen Y; Chen J; Shi Y; Ling X; Fang S; Zhong C; Liu F; Zhong W; Bi X; Dong Z; Lu J
Endocr Relat Cancer; 2024 Mar; 31(3):. PubMed ID: 38224097
[TBL] [Abstract] [Full Text] [Related]
5. Teratoma pathology and genomics in anti-NMDA receptor encephalitis.
Jang Y; Lee K; Lee C; Chu K; Lee SK; Won JK; Lee ST
Ann Clin Transl Neurol; 2024 Jan; 11(1):225-234. PubMed ID: 37986706
[TBL] [Abstract] [Full Text] [Related]
6. Aberrant expression of CKS2 induced by ELK1 contributes to malignant progression of pancreatic cancer.
Chen Q; Fu Y; Liu X; Wang P; Dai S; Zhu F; Liu T; Xu W; Wu J
Mol Carcinog; 2023 Dec; 62(12):1947-1959. PubMed ID: 37642304
[TBL] [Abstract] [Full Text] [Related]
7. Role of Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of prognosis?
De Simoni O; Dal Santo L; Scarpa M; Munari G; Spolverato YC; Scapinello A; Lonardi S; Soldà C; Bergamo F; Fantin A; Bardini R; Pilati P; Fassan M; Gruppo M
Curr Oncol; 2023 Jun; 30(6):5515-5528. PubMed ID: 37366900
[TBL] [Abstract] [Full Text] [Related]
8. Decreased lamin A and B1 expression results in nuclear enlargement in serous ovarian carcinoma, whereas lamin A-expressing tumor cells metastasize to lymph nodes.
Ouchi M; Kobayashi S; Nishijima Y; Inoue N; Ikota H; Iwase A; Yokoo H; Saio M
Pathol Res Pract; 2023 Jul; 247():154560. PubMed ID: 37229920
[TBL] [Abstract] [Full Text] [Related]
9. Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer.
Bartl T; Alberts A; Papadopoulos SC; Wolf A; Muellauer L; Hofstetter G; Grimm C; Cacsire Castillo-Tong D
Int J Gynecol Cancer; 2023 Sep; 33(9):1419-1426. PubMed ID: 37094966
[TBL] [Abstract] [Full Text] [Related]
10. LILRB1
Xu X; Yin S; Wang Y; Zhu Q; Zheng G; Lu Y; Li T; Zhu C
Int Immunopharmacol; 2023 Jun; 119():110162. PubMed ID: 37075669
[TBL] [Abstract] [Full Text] [Related]
11. High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer.
Han GH; Yun H; Chung JY; Kim JH; Cho H
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36999629
[TBL] [Abstract] [Full Text] [Related]
12. Tumor immune microenvironment changes are associated with response to neoadjuvant chemotherapy and long-term survival benefits in advanced epithelial ovarian cancer: A pilot study.
Cao G; Hua D; Li J; Zhang X; Zhang Z; Zhang B; Bei T; Cui L; Chen S; Wang S; Zhu L
Front Immunol; 2023; 14():1022942. PubMed ID: 36993949
[TBL] [Abstract] [Full Text] [Related]
13. Peripheral and tumor-infiltrating immune cells are correlated with patient outcomes in ovarian cancer.
Zhang W; Ling Y; Li Z; Peng X; Ren Y
Cancer Med; 2023 Apr; 12(8):10045-10061. PubMed ID: 36645174
[TBL] [Abstract] [Full Text] [Related]
14. FGFR3 Nuclear Translocation Contributes to Proliferative Potential and Poor prognosis in Pancreatic Ductal Adenocarcinoma.
Zhou L; Lu J; Liang ZY; Zhou WX; Jiang BL; Wang YZ; Liu CX; Huang BW; You L; Guo JC
Pancreas; 2022 May; 51(5):476-482. PubMed ID: 35858182
[TBL] [Abstract] [Full Text] [Related]
15. Advances in targeted therapy for anaplastic thyroid carcinoma.
Qian C; Jiang L; Xu S; Wang J; Tan Z; Xin Y; Ge M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 50(6):685-693. PubMed ID: 35347921
[TBL] [Abstract] [Full Text] [Related]
16. Alternative Splicing: A New Therapeutic Target for Ovarian cancer.
Yao S; Yuan C; Shi Y; Qi Y; Sridha R; Dai M; Cai H
Technol Cancer Res Treat; 2022; 21():15330338211067911. PubMed ID: 35343831
[No Abstract] [Full Text] [Related]
17. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.
Yang X; Zhou S; Yang C; Cao C; He M; Zi S
Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
[TBL] [Abstract] [Full Text] [Related]
18. Prediction of Tumor-Infiltrating cd20
Li Q; Yu J; Zhang H; Meng Y; Liu YF; Jiang H; Zhu M; Li N; Zhou J; Liu F; Fang X; Li J; Feng X; Lu J; Shao C; Bian Y
Acad Radiol; 2022 Sep; 29(9):e167-e177. PubMed ID: 34922828
[TBL] [Abstract] [Full Text] [Related]
19. Contrast-enhanced computed tomography radiomics and multilayer perceptron network classifier: an approach for predicting cd20
Yu J; Li Q; Zhang H; Meng Y; Liu YF; Jiang H; Ma C; Liu F; Fang X; Li J; Feng X; Shao C; Bian Y; Lu J
Abdom Radiol (NY); 2022 Jan; 47(1):242-253. PubMed ID: 34708252
[TBL] [Abstract] [Full Text] [Related]
20. Application of Immunoprofiling Using Multiplexed Immunofluorescence Staining Identifies the prognosis of Patients with High-Grade Serous Ovarian cancer.
Lee SW; Lee HY; Kang SW; Kim MJ; Lee YJ; Sung CO; Kim YM
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502561
[TBL] [Abstract] [Full Text] [Related]
[Next]
